Eucrisa Alternatives Compared
Eucrisa | Rinvoq | Triamcinolone topical |
|
---|
Eucrisa (crisaborole) | Rinvoq (upadacitinib) | Triamcinolone topical |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Atopic Dermatitis. Eucrisa may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Prescription only
Prescribed for Atopic Dermatitis, Dermatitis, Aphthous Ulcer, Allergies, Eczema, Lichen Planus, Psoriasis, Stomatitis. triamcinolone topical may also be used for purposes not listed in this medication guide. View more |
Related suggestions Atopic Dermatitis
Popular comparisons
|
|||||||||||||||||||||||
More about Eucrisa (crisaborole) | More about Rinvoq (upadacitinib) | More about Triamcinolone topical | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Eucrisa has an average rating of 5.9 out of 10 from a total of 282 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 36% reported a negative effect. |
Rinvoq has an average rating of 6.8 out of 10 from a total of 172 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 23% reported a negative effect. |
Triamcinolone topical has an average rating of 7.6 out of 10 from a total of 104 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Eucrisa side effects in more detail. |
See also: Rinvoq side effects in more detail. |
See also: triamcinolone topical side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
||||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Eucrisa prices |
View all Rinvoq prices |
View all triamcinolone topical prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Other upadacitinib brands include: Rinvoq LQ | Aricin, Aristocort A, Aristocort R, Cinalog, Cinolar, Delta-Tritex, DermacinRx Silazone, DermacinRx Trizapak, Dermasorb TA, Juulissa Pharmapak, Kenalog, Kourzeq, Oralone, SilaLite Pak, Treziopak, Trianex, Triasil, Triderm, Tritocin View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
14 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 550 drugs are known to interact with Rinvoq:
|
A total of 48 drugs are known to interact with triamcinolone topical:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
December 14, 2016 |
August 16, 2019 |
October 23, 1958 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.